UHN Research & Innovation Cores Newsletter

Dear Readers,

Welcome to the Fall 2021 issue of the UHN Research & Innovation Cores Newsletter!

This edition takes a comprehensive look at the UHN Molecular Imaging Pipeline. We describe the three-phased molecular imaging pipeline and the role that UHN Research and Innovation Cores play in supporting this process, which strengthens Toronto’s position as a hub for innovation in molecular imaging and theranostics.

This issue also features the UHN Healthcare Human Factors Team and the improvements that they are making in the healthcare environment for clinicians, technicians, patients and other stakeholders.

Finally, we look at The Centre for Cell and Vector Production (CCVP). We highlight the role the facility played in enabling the UHN Islet Cell Transplantation Program to improve patient care for patients suffering from pancreatitis.

Thanks for reading!

Luke Brzozowski

photo of Luk Brzozowski
Executive Lead,
UHN Research & Innovation Cores

UHN Molecular Imaging Pipeline

photo of UHN Molecular Imaging Pipeline

Healthcare Human Factors

photo of organoids

CCVP: Empowering Academic Regenerative Medicine Studies

photo of two researchers

Rebranding Announcement

logo of Princess Margaret Cancer Biobank

We are excited to share with the UHN community the rebranding of the UHN Biobank to the Princess Margaret Cancer Biobank (PMCB).

The program will continue to operate under the leadership of Dr. Neil Fleshner (Medical Director), Heidi Wagner (Head of Operations) and Dr. Hal Berman (Scientific Advisor). The program will also continue to provide top-quality biobanking and digital pathology services in efforts to fuel research and positively impact clinical managing and patient outcomes.

Back to Newsletter Main